Floatz logo

Therapeutic Asset Ratings

1,055 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
VEMURAFENIB
Ovarian Neoplasm
Cancer Research UKP2/3CCC (51)
[18f]f-resca-rt4
Cervical Cancer
RenJi HospitalP2/3CCC (50)
[18f]f-resca-rt4
Endometrial Carcinoma
RenJi HospitalP2/3CCC (50)
[18f]f-resca-rt4
Liver Cancer
RenJi HospitalP2/3CCC (50)
[18f]f-resca-rt4
Lung Cancer
RenJi HospitalP2/3CCC (50)
[18F]F-RESCA-T4
Cervical Cancer
RenJi HospitalP2/3CCC (50)
[18F]F-RESCA-T4
Endometrial Carcinoma
RenJi HospitalP2/3CCC (50)
[18F]F-RESCA-T4
Liver Cancer
RenJi HospitalP2/3CCC (50)
[18F]F-RESCA-T4
Lung Cancer
RenJi HospitalP2/3CCC (50)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Ischemic Stroke
Lower Merion Neurology Research FoundationP2/3CCC (50)
[68ga]ga-nota-rt4
Cervical Cancer
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-rt4
Endometrial Carcinoma
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-rt4
Liver Cancer
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-rt4
Lung Cancer
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-t4
Cervical Cancer
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-t4
Endometrial Carcinoma
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-t4
Liver Cancer
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-t4
Lung Cancer
RenJi HospitalP2/3CCC (50)
ALECTINIB
Lymphoma
Cancer Research UKP2/3CCC (50)
ALECTINIB
Renal Cell Carcinoma
Cancer Research UKP2/3CCC (50)
Amoxicillin
Leukemia
Monash UniversityP2/3CCC (50)
Baricitinib
Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2/3CCC (50)
Baricitinib
Myelodysplastic Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2/3CCC (50)
BOTULINUM B TOXIN
Traumatic Brain Injury
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLCP2/3CCC (50)
Capmatinib
Hematopoietic And Lymphoid System Neoplasm
Cancer Research UKP2/3CCC (50)
Showing 926 to 950 of 1,055 assets
PreviousPage 38 of 43Next